As it continues to develop the evidence base supporting its SpaceOAR system for protecting the rectum during radiation therapy for prostate cancer, Augmenix Inc. is looking to apply similar hydrogel technologies to reducing the collateral damage caused by radiation to treat other cancers.
"[SpaceOAR] is working really well for prostate cancer and we're having really rapid commercial adoption and there are lots of...